Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

Update Il y a 4 ans
Reference: NCT00397293

Woman and Man

Extract

This is an open label, multicenter Phase I/II study to evaluate the safety and efficacy of AT-101 in combination with topotecan in relapsed/refractory small cell lung cancer


Inclusion criteria

  • Small Cell Lung Cancer

Links